On September 3, 2013, Alfred Akirov resigned as a member of the Board of Directors of Protalix BioTherapeutics, Inc. effective immediately, due to increasing demands from his other business interests out of the country, and other time constraints.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | -12.00% | -3.51% | -38.20% |
May. 10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
May. 10 | Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q1 Revenue $3.7M, vs. Street Est of $9.2M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.20% | 80.65M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- Protalix BioTherapeutics, Inc. Announces the Resignation of Alfred Akirov as a Member of the Board of Directors